Research and idea generation for personal use. Not investment advice. See full disclaimer at the bottom.
Top of mind
Tuesday's tape read calm on the surface — the S&P 500 rose 0.3% to 7,677.28, the Nasdaq gained 0.7% to 26,151.30, and the Dow added 0.3% to 53,577.40, all within reach of record territory — but the internals told a rougher story. Dick's Sporting Goods posted its worst single-day loss on record (down roughly 31%) as its Foot Locker acquisition keeps bleeding, Intuit fell about 7% after-hours on soft fiscal 2027 growth guidance despite beating estimates, and Canada finalized 50% retaliatory tariffs on $27.6 billion of US goods effective September 8. None of that will matter much once markets close today: Nvidia reports Q2 results after the bell with Wall Street pricing in roughly $92 billion in revenue, and the reaction will likely decide whether this year's AI trade gets another leg or its first real gut-check.
Market snapshot
(Levels below are Tuesday, August 25 US closes, corroborated across AP/Washington Post and Yahoo Finance/TheStreet coverage.)
| Asset | Level | Change | Notes |
|---|---|---|---|
| S&P 500 | 7,677.28 | +0.3% (+24.42 pts) | Tuesday close; edging toward its August record |
| Nasdaq Composite | 26,151.30 | +0.7% (+171.11 pts) | Tuesday close; chip names firmed into Nvidia's print |
| Dow Jones | 53,577.40 | +0.3% (+160.24 pts) | Tuesday close; third straight session of gains |
| 10Y Treasury | 4.66% | -4 bps | Tuesday close; eased modestly, still elevated by 2026 standards |
| VIX | 15.85 | +4.76% (+0.72 pts) | Tuesday close; still inside the "normal" 15-20 band |
Read-through: Index-level calm masked unusually wide single-name dispersion — a ~31% one-day move in Dick's, a 7% after-hours drop in Intuit, and continued swings in Moderna all happened underneath a VIX that barely budged. That gap between headline volatility and real event risk is the setup heading into Nvidia's binary print tonight.
Headlines & analysis
1. Nvidia reports Q2 after Wednesday's close — the week's defining catalyst
Source: Yahoo Finance, The Motley Fool, Kiplinger So what: Consensus calls for roughly $92 billion in revenue (up about 97% year-over-year) and adjusted EPS near $2.09, both slightly above the company's own guidance of $91 billion. Nvidia is roughly 8% of the S&P 500's weight, so the market's reaction to guidance on hyperscaler capex — not just the headline beat — will set the tone for AI-adjacent stocks into September.
2. Dick's Sporting Goods crashes on Foot Locker drag, worst day on record
Source: CNBC, Forbes, The Motley Fool So what: Core Dick's comparable sales actually grew 4.9%, but the Foot Locker business it acquired last year saw comps fall 3.6%, and bloated sneaker inventory plus heavy discounting forced full-year adjusted EPS guidance down to $11.00-$12.00 from $13.50-$14.50 three months ago. The stock's ~31% drop shows how much execution risk that acquisition still carries, and the footwear-market weakness dragged Nike and Lululemon shares lower in sympathy the same session.
3. Intuit beats on Q4 but guides fiscal 2027 growth down sharply
Source: Seeking Alpha, GuruFocus So what: Intuit's fiscal Q4 adjusted EPS of $4.03 and revenue of roughly $4.35 billion both beat estimates, but fiscal 2027 revenue guidance of just 9%-10% growth — down from 14% in fiscal 2026 — knocked about $6.9 billion off its market value after hours. Management attributed part of the deceleration to a revised stock-based-compensation accounting method rather than deteriorating fundamentals, a claim worth testing against the next quarter's actual print rather than taking at face value.
4. Canada finalizes 50% retaliatory tariffs on $27.6 billion of US goods
Source: Washington Post, Insurance Journal So what: Effective September 8, Canada will impose tariffs of 15%, 25%, and 50% across roughly 700 US products — steel, aluminum, furniture, and clothing hit hardest at 50%, with cheese and appliances at 25% and electronics/tools at 15% — in response to the US's own 50% duties on Canadian goods. Ottawa paired the move with a C$7.5 billion domestic support package, signaling this is a multi-month standoff rather than a one-off skirmish; companies with meaningful cross-border input costs face a real, still-unpriced margin risk once the tariffs land.
5. Moderna's cancer-vaccine rally cools but the stock trades well above formal price targets
Source: BioPharma Dive, Yahoo Finance, Forbes So what: Moderna and Merck's personalized mRNA melanoma vaccine (intismeran autogene) met its primary Phase 3 endpoint, and even after round-tripping some of an initial 177% spike, the stock is still up sharply and trading near $159 — well above the ~$89-91 average analyst price target compiled before the trial news. Wolfe Research upgraded the stock to Peer Perform, but most formal models simply haven't caught up to the news yet, which cuts both ways: upgrades are likely still coming, but so is a real gap-down risk if any post-hoc data scrutiny disappoints.
Ideas — long-term core
Quality businesses, durable competitive advantages, reasonable valuation. Hold horizon: years.
INTU — Intuit
- Thesis: TurboTax, QuickBooks, Credit Karma, and Mailchimp give Intuit a durable, high-margin franchise across consumer tax, small-business software, and fintech — a moat that a single soft guide doesn't undo, especially with Q4 beating on both revenue and EPS.
- Valuation note: The stock is already down roughly 47% from its 2026 peak per pre-earnings coverage, and the fresh 7% after-hours drop pushes the multiple lower still; whether that's now "cheap" depends on how much of the FY27 growth deceleration is real versus the accounting artifact management described.
- Why now (or why patient): This reads as a name to watch through the next print, not to average into blindly — the guide is fresh, unconfirmed as purely technical, and the stock hasn't stabilized yet. Patient entries on further weakness, once the SBC-accounting explanation can be checked against Q1 FY27 actuals, make more sense than buying the initial drop.
- Risks / bear case: If the FY27 deceleration to 9%-10% growth reflects real competitive or demand pressure rather than an accounting reclassification, the stock could re-rate lower for longer; software multiples broadly remain sensitive to any growth disappointment in this market.
Ideas — opportunistic
Catalyst-driven, time-bound, sized smaller. Hold horizon: days to months. Define exit before entry.
NVDA — Nvidia earnings, Wednesday after the close
- Catalyst: Q2 FY27 results tonight, with consensus near $92 billion revenue and $2.09 adjusted EPS against the company's own $91 billion guide; futures were already soft into the print (Nasdaq 100 futures down about 0.5% this morning) after Tuesday's pre-earnings rally.
- Time horizon: Days — this is a binary, single-print event, not a multi-week thesis.
- What would invalidate: A beat paired with cautious hyperscaler-capex commentary — echoing the pattern that hit memory names earlier this month — would argue the "buy the beat" playbook is cracking, not just for this stock but for AI-adjacent semis broadly.
- Risk note: Binary earnings events carry outsized gap risk in both directions; size well below a normal core position given Nvidia's roughly 8% weight in the S&P 500 and the market-wide read-through of tonight's guidance.
MRNA — Moderna, post-catalyst momentum vs. mean-reversion watch
- Catalyst: Positive Phase 3 melanoma-vaccine data with Merck, plus a Wolfe Research upgrade, against a stock now trading roughly 75% above the pre-news average analyst price target — a gap that hasn't been resolved yet.
- Time horizon: Days to a few weeks, watching for either further sell-side upgrades that close the target gap or a stall that signals the move has outrun the fundamentals for now.
- What would invalidate: A break back below this week's post-spike lows without fresh positive newsflow, or a wave of analyst downgrades/cautious notes on trial durability or regulatory timeline, would argue the rally is due for a real reset rather than a pause.
- Risk note: Single-catalyst biotech moves are prone to sharp round-trips (the stock already gave back a chunk of its initial 177% spike once this month); size for binary-outcome volatility, not a smooth trend.
Portfolio-level guidance
Allocation and risk observations. Not specific buy/sell calls — those depend on a full picture this report doesn't see.
- Concentration check: With Nvidia at roughly 8% of the S&P 500 reporting tonight, anyone with meaningful direct or index-level AI-semiconductor exposure is effectively taking a position on the print whether they intend to or not — worth knowing that exposure size going into the close.
- Rates positioning: The 10-year at 4.66% eased modestly Tuesday but remains elevated by 2026 standards, with Thursday's GDP second estimate and Friday's PCE print both live catalysts that could move it further before the week is out.
- Cash & dry powder: This week stacks Wednesday's Durable Goods data and Nvidia's earnings, Thursday's GDP/jobless claims and the start of the Jackson Hole symposium, and Friday's PCE print plus Fed Chair Kevin Warsh's first Jackson Hole keynote. Holding some dry powder through Thursday and Friday rather than committing fully around tonight's Nvidia reaction is a reasonable posture.
- Risk regime read: A VIX at 15.85 looks calm, but Tuesday alone produced a ~31% single-day move in Dick's and a 7% after-hours drop in Intuit — real dispersion under a quiet index-level number. Treat the low VIX print as a floor on complacency risk, not a signal that individual positions are safe from large moves.
- Trade-policy exposure: Canada's 50%/25%/15% tariff tiers take effect September 8 across steel, aluminum, furniture, clothing, cheese, appliances, electronics, and tools — worth a look at any consumer, industrials, or materials holdings with meaningful US-Canada cross-border supply chains before that date.
Watch list — tomorrow / this week
Earnings: Nvidia reports Wednesday, August 26 after the close (~$92B revenue consensus); Marvell follows Thursday, August 27.
Economic data: Durable Goods Orders are due Wednesday; the second estimate of Q2 GDP and initial jobless claims are due Thursday; the PCE price index (the Fed's preferred inflation gauge) and personal income/spending are due Friday.
Fed / central bank: The Kansas City Fed's Jackson Hole Economic Symposium runs Thursday, August 27 through Saturday, August 29. Fed Chair Kevin Warsh delivers his first keynote as chair Friday morning, roughly three weeks ahead of the September 16 FOMC decision.
Other: Watch whether retail-sector weakness broadens beyond Dick's and Foot Locker into Nike, Lululemon, and other footwear-exposed names, and whether Nvidia's guidance settles or reignites this month's memory- and AI-semiconductor volatility.
Disclaimer
This report is prepared for personal research and informational purposes only. It does not constitute investment advice, an offer, or a solicitation to buy or sell any security. Information is drawn from public sources believed to be reliable but is not guaranteed accurate or complete. Markets change rapidly; data may be stale by the time of reading. Any "ideas" mentioned are research candidates, not recommendations, and do not consider any specific person's financial situation, objectives, or risk tolerance. Consult a licensed financial advisor before making investment decisions. Past performance does not predict future results.